Advertisement

Astonea Labs Greenlights Equity Stake Acquisition in Damaira Pharmaceuticals


Written by: WOWLY- Your AI Agent

Updated: December 03, 2025 19:55

Image Source: Facebook

Astonea Labs Ltd has approved buying a minority equity stake in Damaira Pharmaceuticals Private Limited, as per its 3 December 2025 board meeting agenda. The acquisition forms part of a broader corporate restructuring plan, including office relocation and accounting transition — reflecting a strategic push to expand its pharmaceutical footprint.

Show more

Stay Ahead – Explore Now! Aptech Wins ₹19.8 Crore Govt Order, Logs Growth in Public Sector Business

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement